[go: up one dir, main page]

DE60135016D1 - Indolderivate und deren verwendung in medikamenten - Google Patents

Indolderivate und deren verwendung in medikamenten

Info

Publication number
DE60135016D1
DE60135016D1 DE60135016T DE60135016T DE60135016D1 DE 60135016 D1 DE60135016 D1 DE 60135016D1 DE 60135016 T DE60135016 T DE 60135016T DE 60135016 T DE60135016 T DE 60135016T DE 60135016 D1 DE60135016 D1 DE 60135016D1
Authority
DE
Germany
Prior art keywords
hydrogen
hydroxy
indoind
medicaments
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60135016T
Other languages
English (en)
Inventor
Satoshi Sakami
Koji Kawai
Masayuki Maeda
Takumi Aoki
Shinya Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of DE60135016D1 publication Critical patent/DE60135016D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60135016T 2000-11-22 2001-11-22 Indolderivate und deren verwendung in medikamenten Expired - Fee Related DE60135016D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000356382 2000-11-22
PCT/JP2001/010249 WO2002042309A1 (en) 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines

Publications (1)

Publication Number Publication Date
DE60135016D1 true DE60135016D1 (de) 2008-09-04

Family

ID=18828643

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135016T Expired - Fee Related DE60135016D1 (de) 2000-11-22 2001-11-22 Indolderivate und deren verwendung in medikamenten

Country Status (11)

Country Link
US (1) US6770654B2 (de)
EP (1) EP1342723B1 (de)
JP (1) JP4292738B2 (de)
KR (1) KR20030053530A (de)
CN (1) CN1247591C (de)
AT (1) ATE402179T1 (de)
AU (2) AU2002224086B8 (de)
CA (1) CA2427931A1 (de)
DE (1) DE60135016D1 (de)
ES (1) ES2311034T3 (de)
WO (1) WO2002042309A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1424337A1 (de) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-Hydroxyderivate von 5,6,9,10-Tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-on
CN1758912A (zh) * 2003-03-07 2006-04-12 东丽株式会社 药物·物质依赖治疗药
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
WO2008001859A1 (fr) * 2006-06-30 2008-01-03 School Juridical Person Kitasato Gakuen AGONISTE DES RÉCEPTEURS δ DES OPIOÏDES
EP2149370A1 (de) 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabizyclischen Verbindungen und Mikroemulsionen, dieselben enthaltend
IT1390848B1 (it) 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Composti farmaceutici
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
AU2019229892B2 (en) 2018-03-08 2025-01-30 University Of Kansas Treatment of demyelinating diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2197953T3 (es) * 1995-09-26 2004-01-16 Toray Industries, Inc. Derivados de indol y aplicaciones medicas de los mismos.

Also Published As

Publication number Publication date
AU2002224086B1 (en) 2006-11-16
EP1342723A1 (de) 2003-09-10
WO2002042309A1 (en) 2002-05-30
US20040019071A1 (en) 2004-01-29
US6770654B2 (en) 2004-08-03
ES2311034T3 (es) 2009-02-01
EP1342723A4 (de) 2005-02-09
CA2427931A1 (en) 2002-05-30
KR20030053530A (ko) 2003-06-28
ATE402179T1 (de) 2008-08-15
CN1486321A (zh) 2004-03-31
JP2002220391A (ja) 2002-08-09
EP1342723B1 (de) 2008-07-23
AU2408602A (en) 2002-06-03
JP4292738B2 (ja) 2009-07-08
CN1247591C (zh) 2006-03-29
AU2002224086B8 (en) 2002-06-03

Similar Documents

Publication Publication Date Title
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
ATE386725T1 (de) Heterocyclylverbindungen
BR0016951A (pt) Derivado de fenilpiperazinil, composto, composição farmacêutica, uso do mesmo, método de tratamento
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
PT992509E (pt) Novos derivados macrolidos
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
EP1004573A4 (de) Aryloxyanilin-derivate
EP1057813A4 (de) Indol-derivate und medizinische zusammensetzungen die diese enthalten
DE60135016D1 (de) Indolderivate und deren verwendung in medikamenten
ATE445589T1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
ATE315023T1 (de) Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
EP1151993A4 (de) Cyclische aminderivate und ihre anwendungen
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
DK0940401T3 (da) 2-Carbonylthiazolderivater og anvendelse deraf
ATE319452T1 (de) Arzneimittel gegen essstörungen
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE265459T1 (de) Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen
EP1466909A4 (de) Halogenbenzylaminopropionsäurederivate
TH101398A3 (th) การใช้ประโยชน์จากอนุพันธ์ไอโซไธอะโซลเป็นสารต่อต้านมะเร็ง

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee